Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers (NCT00376818) | Clinical Trial Compass
CompletedNot Applicable
Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers
United States4 participantsStarted 2006-06
Plain-language summary
RATIONALE: Yoga, meditation, and breathing exercises may help lower stress and improve quality of life in patients with malignant brain tumors and their family caregivers.
PURPOSE: This clinical trial is studying how well a stress reduction program works to improve the quality of life of patients with malignant brain tumors and their family caregivers.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
DISEASE CHARACTERISTICS:
* Histologically confirmed malignant brain tumor of 1 of the following subtypes:
* Anaplastic astrocytoma
* Glioblastoma multiforme
* Astrocytoma WHO grade IV
* Malignant meningioma
* Anaplastic oligodendroglioma
* Anaplastic oligoastrocytoma
* Gliosarcoma
* Anaplastic ependymoma
* Medulloblastoma
* Caregivers must meet the following criteria:
* Primary family caregiver
* Age 18 and over
PATIENT CHARACTERISTICS:
* Karnofsky performance status 70-100%\*
* Absolute neutrophil count ≥ 1,500/mm³\*
* Platelet count ≥ 100,000/mm³\*
* Bilirubin ≤ 2 times normal\*
* Alkaline phosphatase ≤ 2 times normal\*
* SGOT ≤ 3 times normal\*
* BUN or creatinine ≤ 1.5 times normal\*
* No other prior (within the past 3 years) or concurrent malignancies except for surgically cured carcinoma in situ of the cervix or nonmelanoma skin cancer\*
* Not pregnant\*\*
* Negative pregnancy test\*\*
* Fertile patients must use effective contraception\*\*
* No active infection\*\*
* No medical condition that would interfere with the practice of yoga and meditation\*\* NOTE: \*Patient
NOTE: \*\*Patient and caregiver
PRIOR CONCURRENT THERAPY:
* No other prior or concurrent stress reduction techniques using yoga or meditation\*
* Concurrent standard or investigational chemotherapy, hormonal therapy, immunotherapy, biologic agents, or other complementary and alternative therapies as the primary or adjuvant treatment allowed (patient)
* No concurrent glucocort…
What they're measuring
1
Quality of life as measured by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 Items (EORTC QLQ-C30) and Brain Cancer Module-20